Insider · CIK 0001255927

Kania Edwin M Jr

CIK 0001255927 Name as filed on the most recent filing

Filed as Kania Edwin M Jr (40)

126 transaction lines · from 40 filings · filed 2004-12-06 to 2021-11-30 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

35 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2014-12-09 S, Open-market sale BG Medicine, Inc.BGMD 2 lines 47,552, disposed Open Form 4 filing 0001181431-14-038645
2014-12-03 S, Open-market sale BG Medicine, Inc.BGMD 3 lines 850, disposed Open Form 4 filing 0001181431-14-038231
2014-12-03 S, Open-market sale BG Medicine, Inc.BGMD 5 lines 1,133, disposed Open Form 4 filing 0001181431-14-038230
2014-12-03 S, Open-market sale BG Medicine, Inc.BGMD 5 lines 118, disposed Open Form 4 filing 0001181431-14-038228
2014-12-03 S, Open-market sale BG Medicine, Inc.BGMD 5 lines 120, disposed Open Form 4 filing 0001181431-14-038229
2014-05-05 S, Open-market sale Acceleron Pharma IncXLRN 2 lines 9,220,986, disposed Open Form 4 filing 0001209191-14-031623
2014-04-24 S, Open-market sale Acceleron Pharma IncXLRN 2 lines 26,877,736, disposed Open Form 4 filing 0001209191-14-029095
2014-04-23 S, Open-market sale Acceleron Pharma IncXLRN 2 lines 801,297, disposed Open Form 4 filing 0001209191-14-029095
2014-04-22 S, Open-market sale Acceleron Pharma IncXLRN 2 lines 4,367,167, disposed Open Form 4 filing 0001209191-14-029095
2014-02-11 P, Open-market purchase Eleven Biotherapeutics, Inc.EBIO 3 lines 3,787,290, acquired Open Form 4 filing 0001181431-14-006845
2013-11-18 S, Open-market sale Receptos, Inc.RCPT 489,027, disposed Open Form 4 filing 0001181431-13-059544
2013-11-15 S, Open-market sale Receptos, Inc.RCPT 2 lines 1,329,490, disposed Open Form 4 filing 0001181431-13-059544
2013-11-14 S, Open-market sale Receptos, Inc.RCPT 3,894,242, disposed Open Form 4 filing 0001181431-13-059544
2013-09-25 P, Open-market purchase Bind Therapeutics, IncBIND 300,000, acquired Open Form 4 filing 0001209191-13-045956
2013-05-14 P, Open-market purchase Receptos, Inc.RCPT 1,499,988, acquired Open Form 4 filing 0001104659-13-041517
2013-03-25 P, Open-market purchase Tetraphase Pharmaceuticals IncTTPH 3,442,768, acquired Open Form 4 filing 0001181431-13-019227
2013-01-30 P, Open-market purchase BG Medicine, Inc.BGMD 5 lines 4,000,000, acquired Open Form 4 filing 0001181431-13-006146
2012-08-20 S, Open-market sale BG Medicine, Inc.BGMD 4 lines 478, disposed Open Form 4 filing 0001181431-12-046973
2012-05-21 S, Open-market sale BG Medicine, Inc.BGMD 142, disposed Open Form 4 filing 0001181431-12-032084
2012-05-21 S, Open-market sale BG Medicine, Inc.BGMD 142, disposed Open Form 4 filing 0001181431-12-032084
2012-05-21 S, Open-market sale BG Medicine, Inc.BGMD 142, disposed Open Form 4 filing 0001181431-12-032084

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 3
  • Open-market sale 32
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. KANIA EDWIN M JR, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001255927

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.